Chemoinformaics analysis of CHAVIBETOL
Molecular Weight | 164.204 | nRot | 3 |
Heavy Atom Molecular Weight | 152.108 | nRig | 7 |
Exact Molecular Weight | 164.084 | nRing | 1 |
Solubility: LogS | -2.354 | nHRing | 0 |
Solubility: LogP | 2.344 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 26.3055 |
nHD | 1 | BPOL | 13.7745 |
QED | 0.693 |
Synth | 2 |
Natural Product Likeliness | 1.008 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0 |
HIA | 0.007 |
CACO-2 | -4.387 |
MDCK | 0.0000303 |
BBB | 0.173 |
PPB | 0.917667 |
VDSS | 0.831 |
FU | 0.0322174 |
CYP1A2-inh | 0.923 |
CYP1A2-sub | 0.942 |
CYP2c19-inh | 0.739 |
CYP2c19-sub | 0.647 |
CYP2c9-inh | 0.334 |
CYP2c9-sub | 0.877 |
CYP2d6-inh | 0.856 |
CYP2d6-sub | 0.916 |
CYP3a4-inh | 0.392 |
CYP3a4-sub | 0.391 |
CL | 14.201 |
T12 | 0.869 |
hERG | 0.024 |
Ames | 0.06 |
ROA | 0.103 |
SkinSen | 0.821 |
Carcinogencity | 0.82 |
EI | 0.978 |
Respiratory | 0.485 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.894062 |